Can, Bilge <br/><br/>
Thymosin β4 is a novel potential prognostic marker in gastrointestinal stromal tumors.  [electronic resource] 

 -  APMIS : acta pathologica, microbiologica, et immunologica Scandinavica  Sep 2012 
 - 689-98 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1600-0463 
<br/><br/><label>Standard No.: </label>10.1111/j.1600-0463.2012.02887.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Biomarkers, Tumor--metabolism<br/>Disease-Free Survival<br/>Female<br/>Gastrointestinal Neoplasms--metabolism<br/>Gastrointestinal Stromal Tumors--metabolism<br/>Humans<br/>Immunohistochemistry<br/>Kaplan-Meier Estimate<br/>Male<br/>Middle Aged<br/>Retrospective Studies<br/>Thymosin--metabolism<br/>Vascular Endothelial Growth Factor A--metabolism